1
|
González-Moreno P, Araujo-Sánchez M, Fernández-Suárez J, Fernández-Dominguez J, Llorente JL, Zapico-González MS. Auritidibacter ignavus in ear discharge of paediatric patients: Two cases reports and literature review. Enferm Infecc Microbiol Clin (Engl Ed) 2024; 42:202-204. [PMID: 38262875 DOI: 10.1016/j.eimce.2024.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 10/16/2023] [Accepted: 10/30/2023] [Indexed: 01/25/2024]
Abstract
INTRODUCTION The development and research of new technologies for identifying microorganisms, has allowed the identification of hitherto unknown bacteria. Auritidibacter ignavus is a newly described Gram-positive rod possibly associated with otitis, although its role as an etiologic agent in otitis is currently controversial. METHODS We report two cases of recurrent otitis in paediatric patients in which A. ignavus was isolated and review the previous cases reported in the literature. RESULTS All the isolates were identified as A. ignavus by proteomic and genomic methods. Both patients recovered from their symptoms. CONCLUSION A. ignavus was recovered from ear discharges of paedriatic patients with chronic ear problems. All the cases previously reported in the literature were adults. More evidence is needed for the association between A. ignavus and otitis, since data regarding this species are still scarce.
Collapse
Affiliation(s)
- Pablo González-Moreno
- Servicio de Microbiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
| | - Martina Araujo-Sánchez
- Servicio de Microbiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
| | - Jonathan Fernández-Suárez
- Servicio de Microbiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Spain
| | - Javier Fernández-Dominguez
- Servicio de Microbiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Spain
| | - Jose Luis Llorente
- Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
| | | |
Collapse
|
2
|
Roth S, Linxweiler M, Rehner J, Schmartz GP, Becker SL, Kühn JP. Auritidibacter ignavus, an Emerging Pathogen Associated with Chronic Ear Infections. Emerg Infect Dis 2024; 30. [PMID: 38146955 PMCID: PMC10756363 DOI: 10.3201/eid3001.230385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2023] Open
Abstract
We describe detection of the previously rarely reported gram-positive bacterium Auritidibacter ignavus in 3 cases of chronic ear infections in Germany. In all 3 cases, the patients had refractory otorrhea. Although their additional symptoms varied, all patients had an ear canal stenosis and A. ignavus detected in microbiologic swab specimens. A correct identification of A. ignavus in the clinical microbiology laboratory is hampered by the inability to identify it by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Also, the bacterium might easily be overlooked because of its morphologic similarity to bacterial species of the resident skin flora. We conclude that a high index of suspicion is warranted to identify A. ignavus and that it should be particularly considered in patients with chronic external otitis who do not respond clinically to quinolone ear drop therapy.
Collapse
|
3
|
Bernard KA, Pacheco AL, Burdz T, Wiebe D, Beniac DR, Hiebert SL, Booth TF, Jakopp B, Goldenberger D, Seth-Smith HMB, Egli A, Bernier AM. Emendation of the Genus Auritidibacter Yassin et al. 2011 and Auritidibacter ignavus Yassin et al. 2011 based on features observed from Canadian and Swiss clinical isolates and whole-genome sequencing analysis. Int J Syst Evol Microbiol 2020; 70:83-88. [PMID: 31596191 DOI: 10.1099/ijsem.0.003719] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Auritidibacter ignavus is a Gram-stain-positive bacillus derived from otorrhea. Four strains derived from ear discharges in Canada and Switzerland, with features consistent with but distinguishable from Auritidibacter ignavus IMMIB L-1656T (accession number FN554542) by 16S rRNA gene sequencing (97.5 % similarity), were thought to represent a novel species of the genus Auritidibacter. Auritidibacter ignavus DSM 45359T (=IMMIB L-1656T) was acquired to compare with Canadian and Swiss strains by whole-genome sequencing (WGS). Unexpectedly, those isolates were observed to be consistent with A. ignavus DSM 45359T by WGS (ANIb scores >98 %), MALDI-TOF (Bruker), cellular fatty acid analysis and biochemically (some differences were observed). A nearly full 16S rRNA gene sequence could not be readily prepared from A. ignavus DSM 45359T, even after multiple attempts. A 16S rRNA gene chimeric consensus sequence created from the genome assembly of A. ignavus DSM 45359T had only 97.5 % similarity to that of A. ignavus IMMIB L-1656T, implying that 16S rRNA sequence accession number FN554542 could not be replicated. We concluded that our isolates of members of the genus Auritidibacter were consistent with A. ignavus DSM 45359T, did not represent a novel species, and that the sequence corresponding to FN554542 was not reproducible. By WGS, A. ignavus DSM 45359T had genome of 2.53×106 bp with a DNA G+C content of 59.34%, while genomes of Canadian and Swiss isolates ranged from 2.47 to 2.59×106 bp with DNA G+C contents of 59.3-59.52 %. A. ignavus NML 100628 (=NCTC 14178=LMG 30897) did not demonstrate a rodcoccus cycle. Emendation of Auritidibacter ignavus was proposed based on these results.
Collapse
Affiliation(s)
- K A Bernard
- Department of Medical Microbiology, University of Manitoba, Winnipeg Manitoba, Canada.,National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg Manitoba, Canada
| | - A L Pacheco
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg Manitoba, Canada
| | - T Burdz
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg Manitoba, Canada
| | - D Wiebe
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg Manitoba, Canada
| | - D R Beniac
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg Manitoba, Canada
| | - S L Hiebert
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg Manitoba, Canada
| | - T F Booth
- Department of Medical Microbiology, University of Manitoba, Winnipeg Manitoba, Canada.,National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg Manitoba, Canada
| | - B Jakopp
- Present address: Infectious Diseases Unit, Katonsspital Aarau, Aarau, Switzerland.,Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland
| | - D Goldenberger
- Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
| | - H M B Seth-Smith
- Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.,Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
| | - A Egli
- Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
| | - A-M Bernier
- Department of Biology, Université de Saint-Boniface, Winnipeg Manitoba, Canada
| |
Collapse
|